Evaluation of cyclosporine 0.05% and artificial tears for the management of dry eye disease following cataract surgery: a randomized controlled trial
Open Access
- 9 February 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 86 (4) , 1983-1988
Abstract
Purpose: To compare the effects of cyclosporine 0.05% and artificial tears on dry eye disease following cataract surgery. Methods: This prospective, double-masked, randomized clinical trial enroled 60 eyes of 60 eligible cataract patients who completed the study. Patients were randomized to receive either cyclosporine 0.05% or artificial tear four times daily for 1 month following cataract surgery. Clinical assessments included refraction, corrected distance visual acuity, tear break-up time (TBUT), Schirmer’s test, and the visual analogue scale (VAS). An independent sample t-test was used to compare the means of the variables between the two groups. Results: Mean patient age was 64.15±9.17 (range, 45–90), of which 53% (n=32) were female. There was no significant difference in mean age (P=0.308) between the two groups. One month postoperatively, the cyclosporine 0.05% group had a significantly higher TBUT value (P=0.004). Schirmer’s result (P=0.095) and the VAS questionnaire scores (P=0.374) did not show a statistically significant difference between the two groups. There was no significant difference in the visual outcomes (P>0.05). Conclusion: Cyclosporine 0.05% was superior to artificial tears in improving tear stability after cataract surgery in the management of immediate postoperative dry eye. It may provide a more effective therapeutic option for the management of dry eye symptoms in the clinical setting.Keywords
This publication has 37 references indexed in Scilit:
- Evaluation of Dry Eye and Meibomian Gland Dysfunction After Cataract SurgeryAmerican Journal of Ophthalmology, 2014
- The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract SurgeryKorean Journal of Ophthalmology, 2013
- Effect of Tear Hyperosmolarity and Signs of Clinical Ocular Surface Pathology upon Conjunctival Goblet Cell Function in the Human Ocular SurfaceInvestigative Ophthalmology & Visual Science, 2011
- Cyclosporine 0.05% to improve visual outcomes after multifocal intraocular lens implantationJournal of Cataract & Refractive Surgery, 2010
- Topical Cyclosporine 0.05% for the Prevention of Dry Eye Disease ProgressionJournal of Ocular Pharmacology and Therapeutics, 2010
- Development and Validation of a Short Global Dry Eye Symptom IndexThe Ocular Surface, 2007
- Classifying the Severity of Corneal Ulcers by Using the “1, 2, 3” RuleCornea, 2007
- Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacyCritical Reviews in Oncology/Hematology, 2005
- Goblet Cell Numbers and Epithelial Proliferation in the Conjunctiva of Patients With Dry Eye Syndrome Treated With CyclosporineArchives of Ophthalmology (1950), 2002
- Analysis of Topical Cyclosporine Treatment of Patients With Dry Eye SyndromeEffect on Conjunctival LymphocytesArchives of Ophthalmology (1950), 2000